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Objective:  To describe  the  characteristics  of patients  hospitalized  for osteoporotic  proximal  humerus
fracture  in  2009  in France,  in-patient  mortality,  and  further  hospitalizations  for hip  fracture.
Methods:  Data  were  extracted  from  the  French  Hospital  National  Database.  We  selected  patients  aged
40 years  and  over  hospitalized  for  proximal  humerus  fracture  in  2009,  without  cancer.  Based  on  their
unique  identiﬁcation  number,  we  described  the  next hospitalizations  occurring  in  2009–2011  whatever
the  causes.  Incidence,  in-patient  mortality,  and  hospital  costs  were  calculated.
Results: We  numbered  10,874  patients  (77%  of women,  mean  age  72.5  years).  The  incidence  per  million
was  477  and  163  in  women  and  men,  respectively.  This  incidence  increased  with  age  and  was  higher  in
women  (i.e.  1374  and  320 in  women  and  men  aged  over 74 years,  respectively).  Surgical  treatment  was
applied  in 56%  of  patients;  median  hospital  stay  was  5 days. Rehabilitation  unit  was  necessary  in 26%
of  cases.  In-patient  mortality  was  1.1%. The  overall  hospital  costs  was  D 34  millions.  Rehospitalizations
occurred  for  61% of the  patients  and  had more  co-morbidities  than  others.  Near  8% of the  rehospital-
ized  patients  were  for  hip  fractures  occurring  in  a  median  of  353  days  after  hospitalization  for  proximal
humerus  fracture.  The  hospital  costs  for these  rehospitalizations  was  D  52 millions.
Conclusion:  Proximal  humerus  fractures  incidence  increases  with  aging,  especially  in  women.  These frac-
tures  are associated  with  a signiﬁcant  in-patient  mortality  and  health  care  resources  utilization.  Patients
with  such fracture  must  receive  high  priority  for optimal  post  fracture  treatment.
© 2014  Elsevier  Masson  SAS.  All  rights  reserved.. Introduction
Proximal humeral fractures (PHF) are the third most frequent
on-vertebral fractures in the elderly, after hip and forearm frac-
ures; the majority of them can be treated non-operatively, with
arious durations of arm immobilization; several months are nec-
ssary for good recovery [1]. Patients are at risk for falls and
ubsequent fractures within a year after the PHF; during this period
f time, there is a 6-fold increase in the risk of sustaining a hip frac-
ure [2]. Moreover, an excess of mortality in women with PHF has
een reported in prospective studies [3]; mortality is signiﬁcantly
∗ Corresponding author. Hôpital Lariboisière, Fédération de rhumatologie, 2, rue
mbroise-Paré, 75475 Paris cedex 10, France. Tel.: +33 1 49 95 62 91;
ax: +33 1 49 95 86 31.
E-mail address: mmaravic2010@gmail.com (M.  Maravic).
1 www.cfmr.fr.
http://dx.doi.org/10.1016/j.otsr.2014.09.017
877-0568/© 2014 Elsevier Masson SAS. All rights reserved.increased immediately after the fracture, and is not signiﬁcantly
different from mortality of the general population at 5 years [4].
As the population ages, the incidence of such fractures is
expected to increase. There is no current information about the
number of PHFs supposed to be due to osteoporosis, their cost
and in-patient mortality in France. The aims of our study were to
describe the population of patients hospitalized for PHF in 2009, to
assess in-patient mortality, and to describe the further hospitaliza-
tions of these patients. We  hypothesized that patients presenting
with PHF and co-morbidities are at higher risk of rehospitalization
and occurrence of other osteoporotic fracture, such as hip one.
2. Methods2.1. Source of data
The data were extracted from the French hospital national
database in acute care setting, which has been previously used
9 tology: Surgery & Research 100 (2014) 931–934
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o assess the burden of osteoporotic hip, proximal humerus and
ertebral fractures in France [5–7]. This database includes 100% of
ospitalizations occurring in both public and private acute care set-
ing in France. Health professionals gather the information using
CD-10 codes. A number of variables including co-morbidities can
e assessed, but treatments are not available. According to our
bjectives, we selected stays due to the ﬁrst management of PHF
n 2009 for patients aged more than 40 years, and the next hos-
italizations occurring whatever the cause from 2009 to 2011 for
hese patients. Brieﬂy, we  performed two extractions. The ﬁrst one
n order to identify the patients aged 40 years and over on their
nique identiﬁcation number related to hospitalization for PHF in
009 (ICD-10 codes encoded as primary diagnosis: S42.2, M80. 1,
81.–1) classiﬁed in medical and surgical disease-related group
DRG) related to PHF management, except for polytrauma which
ere excluded. We numbered 14,408 hospitalizations (13,719
atients) corresponding to the 80% of stays having PHF encoded
s primary diagnosis. The second one corresponded to all hospital-
zations occurring from 2009 to 2011 (included) for these patients.
f a patient was hospitalized for a controlateral PHF, only the ﬁrst
ospitalization was identiﬁed as belonging to the PHF group and
he other hospitalization was taken into account as a further hos-
italization. We  excluded patient whose stays mentioned a cancer
isease or was classiﬁed in an unclassiﬁed DRG after using the
ast classiﬁcation of DRGs. Our ﬁnal selection focused on 10,874
atients (i.e. 79% of the initial selection) and 23,213 hospitaliza-
ions described as followed: 37% for PHF, 63% after PHF whatever
he reason during the study period from 2009 to 2011.
.2. Analysis of data
We  performed a description of the patients hospitalized for PHF
n 2009: the patients’ characteristics (gender, age, co-morbidities),
nd the characteristics of the hospitalizations (mode of entry and
ischarge, length of stay, need of intensive care, type of manage-
ent, hospital costs). Co-morbidities were described according to
he ICD-10 codes. In-patient mortality was described for any hos-
italization, and we calculated the time between discharge after
HF and the stay ended with death. We  described characteristics
f patients rehospitalized for hip fractures.
We  calculated the incidence of PHF per million inhabitants
sing the information of the 2012 estimated French population
www.insee.fr) and expressed the information according to differ-
nt ages groups (40–59, 60–74, and ≥ 75 years) and gender.
For economic evaluation, we applied the 2012 public tariff per
isease-related group (DRG) after reclassiﬁcation of all stays in
he 11c version of the classiﬁcation of DRG for the study period
009–2011 (classiﬁcation used in 2011). In this method, if one stay
as unclassiﬁed in the last DRG version, all stays of this given
atient were excluded in the overall analysis. We  took into account
he variation of the tariff according to the duration of stay and
he additional tariff due to the management in intensive care units
r dialysis during the stay. The additional costs of the material of
steosynthesis or prosthesis, which is for some of them paid in addi-
ion to the tariff per DRG, was not calculated. Costs were expressed
n equivalent 2012 euros.
We performed descriptive statistics as mean (standard devia-
ion, SD) or median (minima–maxima), only.
. Results.1. Incidence of PHF
In 2009 in France, 10,874 patients aged more than 40 years were
ospitalized for PHF. The incidence per million adults aged 40 yearsFig. 1. Incidence per million for PHF in 2009 (2012 French population).
and over is reported in Fig. 1; it ranged from 130 to 980 per million
in patients aged 40–59 and ≥ 75 years, respectively. As expected the
incidence was  higher in women  than in men  after the age of 60.
3.2. First hospitalization for PHF in 2009
Among the 10,874 patients, 77% of them were women, and the
mean age of this population was 72.5 (13.8) years. The vast major-
ity of these patients (96%) were previously at home. They received
medical treatment (44%), or osteosynthesis (44%) or shoulder pros-
thesis (12%) The mean (standard deviation) hospital stay was  6.7
(6.7) days, median (minima–maxima) 5 days (0–139). The median
hospital stay was  longer in women  than in men: median 5 (10–139)
and 4 (0–71), days respectively. In the majority of cases (64%),
patients returned to home, but the mode of discharge was a reha-
bilitation unit for 26%; 855 (8%) patients were referred to an acute
care unit. Sixty-one percent of them had at least one comorbid-
ity. The in-patient mortality was  1.1%, 0.9%, and 1.5% in the overall
population, women and men, respectively. The total costs related
to these hospitalizations in 2009 was D 33.6 millions (Table 1).
3.3. Further hospitalizations 2009–2011
Among these 10,874 patients, 6588 (61%) were rehospitalized
between 2009 and 2011 (16,118 rehospitalizations). The mean
number of rehospitalizations was  2.78 (9.62), and the median 2
(1–440), respectively. The higher number of rehospitalizations is
related to 21 patients receiving iterative dialysis.
Patients with further hospitalizations were older and had more
co-morbidities than the others, as shown in Table 2. There was no
difference in the duration of stay of the ﬁrst hospitalization. The in-
patient mortality reached 3.5% during the ﬁrst rehospitalization,
and was  2.4%, 1.3% and less than 1% during the second, third, and
further hospitalizations, respectively. Thus, the in-patient mortal-
ity rate over 3 years in-patients hospitalized for a PHF in 2009 is
6.7% (i.e. 612 patients). In-patient death occurred 361 (273) days
with a median of 332 days after the hospitalization for PHF.
Among these 6588 patients, 7.5% were rehospitalized because
of a hip fracture, occurring in a mean of 381 (281) days (median:
353 days) after hospitalization for PHF. In this population, 86% were
women; the mean age was 82.2 (10.8). As shown in Table 2, patients
with hip fracture were older and had more co-morbidities than
patients without hip fracture. The overall costs of these rehospital-
izations was D 52.2 millions.
4. Discussion
This study shows that the overall incidence rate of hospital-
ized osteoporotic PHF in adults after the age of 40 years is 477 and
163 per million in women  and men, respectively, reaching 1374 per
million in women after the age of 75. In these patients hospitalized
for PHF, the in-patient mortality rate over 3 years is 6.7%.
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Table  1
Characteristics of patients hospitalized for PHF in 2009 according to the occurrence
of  a further hospitalization over the next 2 years (n = 10,874).
Further hospitalization
Population No Yes
Demography
Patients: number (%) 4286 (39) 6588 (61)
Women  39% 61%
Age:  (SD) 71.7 (14.0) 73.1 (13.6)
Co-morbidities described as a
secondary diagnosis (ICD-10 codes)a
Arrhythmia (I44–I49) 2.6%–6.7% 13.0%–21.4%
Arteriopathy (I70, I74) 0.3%–0.8% 3.2%–5.2%
Cardiac failure (I50) 1.0%–2.5% 7.4%–12.3%
Chronic obstructive pulmonary
disease (J44)
0.5%–1.3% 3.9%–6.5%
Coronaropathy (I20–I25, without
I23)
1.4%–3.7% 7.8%–12.9%
Dementia (F00–F03, G30–G32) 2.5%–6.3% 10.9%–18%
Diabetes (E10–E14) 3.2%–8.2% 10.5%–7.3%
Dyslipidemia (E78) 2.7%–6.8% 8.9%–14.7%
Tendency to fall (R29.6) 0.5%–1.2% 4.9%–8.1%
Hypertension (I10–I13) 11.3%–28.6% 30.0%–49.4%
Obesity (E66.–) 1.5%–3.8% 5.6%–9.2%
Parkinson (G20–G22) 0.4%–1% 2.0%–3.3%
Renal failure (N18) 0.5%–1.2% 4.0%–6.5%
Stroke (recent event or sequella)
(G45–G46, I60–I64, I69)
1.0%–2.5% 6.1%–10.1%
The ﬁrst percentages are calculated using the overall population (i.e. 10,874) as
a  denominator, and the second using the subgroup of no further hospitaliza-
tion (n = 4286) or further hospitalization (n = 6588) as a denominator, respectively.
ICD-10 codes: international statistical classiﬁcation of diseases and related health
problems, 10th revision, PHF: proximal humerus fracture.  (SD): mean (standard
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Teviation).
a The comparison of the frequency of comorbidity is higher in the rehospitalized
atients than in non-rehospitalized.
The incidence of PHF is higher in women than in men, and
ncreases dramatically with age. These characteristics are common
ith other osteoporotic fractures, such as hip, vertebral [5,6] and
elvic fracture [8]. Risk factors for PHF are similar to those of other
on-vertebral fractures, i.e. related to bone fragility and fall-related
actors [9]. PHF, and wrist fractures share common risk factors,
ncluding low femoral neck bone mineral density (BMD) [10]. Actu-
lly aging is associated with declines in proximal humeral bone
roperties, including BMD  decrease, as measured by dual-energy X-
ay absorptiometry [11]. Declines in cortical bone mass, areas and
able 2
haracteristics of patients hospitalized for PHF who  had a hip fracture in the 2
ollowing years.
Hip fracture
Population No Yes
Demography
Patients: number 6,091 497
Women  76.3% 86.1%
Age:  (SD) 73.3 (13.6) 82.2 (10.8)
Co-morbidities (%)
Arrhythmia 20.7 29.6
Arteriopathy 5.2 5.0
Cardiac failure 13.1 17.9
Chronic obstructive pulmonary disease 6.6 5.6
Coronaropathy 12.6 16.5
Dementia 16.5 35.8
Diabetes 17.4 15.9
Dyslipidemia 15.1 9.5
Tendency to fall 7.5 14.5
Hypertension 48.6 59.6
Obesity 9.5 2.6
Parkinson 3.0 6.4
Renal failure 6.4 8.0
Stroke (recent event or sequella) 10.0 11.1
he percentages are calculated using the number of patients of each group.: Surgery & Research 100 (2014) 931–934 933
thickness of proximal humerus have been measured using periph-
eral quantitative computed tomography in a cross sectional study of
170 healthy males [11]. Such data are very similar to those obtained
at other bones, including hip. There is thus a rationale to explain
why femoral neck BMD  is a risk factor for PHF [9,10], and why  PHF
is predictive of subsequent hip [2], and other fractures [12].
In our study, a hip fracture occurred in 7.5% of the patients
with PHF over 3 years. These patients were different from those
without hip fracture. They were older, had more cardiovascular
co-morbidities, and the proportion of patients with dementia was
higher (35.8% versus 16.5%). The proportion of patients with Parkin-
son disease was two-fold, and attention has been paid recently on
this relevant risk factor for falls and fractures [13].
In the study of osteoporotic fracture, conducted in women
65 years of age and older, 13.7% of patients who had a PHF sustained
a hip fracture over 9 years of follow-up [2]. These data strongly
suggest that patients with PHF must receive a high priority for
both pharmacological and non-pharmacological interventions. A
fast return to pre-fracture physical performance and functional
status must be the goal of the rehabilitation program, with lim-
itation of the immobilization period [1]. Attention must be paid
on patient’s ability to walk, decreased balance and reaction time
related to arm immobilization, which increases in terms of the risk
of falls. It is noteworthy that 96% of our patients were at home
before the fracture, and that only 64% of them returned to home
after the hospitalization.
This is the ﬁrst study assessing rehospitalizations after hospi-
talization for PHF. Actually the rate of rehospitalization was huge,
concerning 61% of our patients, suggesting a high level of fragility
in patients hospitalized for PHF. Actually, the proportion of these
patients having at least one comorbidity at the time of PHF was
61%, which is higher than the proportion of 53% we observed in
the same database in patients hospitalized for vertebral fracture
[6]. Patients with rehospitalization over 3 years were slightly older
than the others, but had more co-morbidities, including cardiovas-
cular diseases and diabetes, and had a higher tendency for falling.
Interestingly the proportion of patients with obesity was higher in
this group as compared to those without rehospitalizations. The
consequences of obesity on fracture risk have been recently recog-
nized, [14]; a site-speciﬁc increased risk has been suggested and
obesity increases the risk of PHF [15].
In-patient mortality was 6.7% over 3 years; the relevant obser-
vation is that the in-patient mortality was 3.5% at the ﬁrst
hospitalization, decreasing thereafter. This is in line with previous
studies suggesting that the increase mortality related to PHF is sig-
niﬁcant in the year following the fracture [4]. This result is similar or
higher than the in-patient mortality patients hospitalized for ver-
tebral fracture [6]. As shown with other fracture [4], mortality rate
was higher in men  than in women. The declining mortality with
time suggests that at least a part of deaths are causally related to
the fracture itself, or to a comorbidity strongly associated with it.
We cannot draw any deﬁnite conclusion, as overall mortality is not
collected in our database, focusing only on in-patient mortality.
PHF incidence was  previously evaluated in France in 2001 [7].
Comparisons of incidence must be cautious because of the follow-
ing parameters: potential differences in the selected data focused
on stay and not on patients, patients older than 45 years with differ-
ent age-classes, calculation of the incidence using the 1999 French
population, impact of the change in payment of French hospital
occurred in 2004. A rise in the rate of PHF  has been observed in
Finland from the 1970s until mild 1990s [16], with stabilization
thereafter [17]. In the same country, a stabilized or even decreased
rate was  observed between 1970 and 2007 for distal humerus
fractures [18]. Bone densitometry and treatments for osteoporo-
sis prevention have been reimbursed in France in 2006, although
there is no evidence that this is the cause of our observations. Other
9 tology
f
v
d
t
e
h
s
n
a
w
n
p
3
o
m
h
m
a
b
D
m
n
m
5
a
m
m
i
f
D
c
A
R
[
[
[
[
[
[
[
[
[
fractures of elderly women, nationwide statistics in Finland between 1970 and34 M. Maravic et al. / Orthopaedics & Trauma
actors such as global health improvement and campaigns of pre-
ention of falls can impact on this result.
The strengths of our study are the exhaustivity of the fracture
ata in the database we used, and the high degree of follow-up at
he individual level through a single identiﬁcation number. How-
ver, the study has several limitations. We  dealt only with patients
ospitalized for PHF. We  do not have information on patients with
uch fracture who are treated at the emergency department and
ot hospitalized. They may  be less frail, with less co-morbidities,
nd thus our results do not apply to the whole population of adults
ith a PHF. Moreover, it is possible that a decision to hospitalize or
ot a patient is based on local guidelines of the hospital, beyond the
atient’s health, and we cannot control for that. In a recent study,
25 patients managed in an emergency unit experienced PHF and
nly 43% of them were hospitalized [19]. We  do not have infor-
ation on the circumstances of the fracture, and cannot exclude
igh trauma fractures, except for those occurring in a context of
ultitrauma. However, our data are very close to the ones usu-
lly observed in patients with fragility fractures. Finally, data on
one mineral density, lifestyle and treatments, including vitamin
 and anti-osteoporotic drugs are not available in the database. Co-
orbidities are available as associated codes; height and weight are
ot recorded, and our data on obesity cannot be validated by body
ass index calculation.
. Conclusion
The number of proximal humerus fractures increases with
ging, these fractures are associated with a signiﬁcant in-patient
ortality and health care resources. Patients with such fracture
ust receive high priority for optimal post fracture management
ncluding rehabilitation in order to lower the risk of subsequent
alls.
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